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Abstract
Background: The Brucella genome contains an insertion sequence (IS) element called IS711 or
IS6501, which is specific to the genus. The copy number of IS711 varies in the genome of the
different Brucella species, ranging from 7 in B. abortus, B. melitensis and B. suis to more than 30 in B.
ovis and in Brucella strains isolated from marine mammals. At present, there is no experimental
evidence of transposition of IS711, but the occurrence of this element with a high copy number in
some species, and the isolation of Brucella strains with "ectopic" copies of IS711 suggested that this
IS could still transpose.
Results: In this study we obtained evidence of transposition of IS711 from the B. ovis and B.
pinnipedialis chromosomes by using the "transposon trap" plasmid pGBG1. This plasmid expresses
resistance to tetracycline only if the repressor gene that it contains is inactivated. The strains B.
melitensis 16 M, B. abortus RB51, B. ovis BOC22 (field strain) and B. pinnipedialis B2/94, all containing
the plasmid pGBG1, were grown in culture media with tetracycline until the appearance of
tetracycline resistant mutants (TcR). TcR mutants due to IS711 transposition were only detected in
B. ovis and B. pinnipedialis strains.
Conclusion: Four different copies of IS711 were found to transpose to the same target sequence
in the plasmid pGBG1. This demonstrated that IS711 are active in vivo, specially in Brucella species
with a high number of IS711 copies as B. ovis and B. pinnipedialis.
Background
Bacteria in the genus Brucella are the etiological agents of
brucellosis, one of the most important zoonotic diseases,
affecting human and domestic animals of high economic
and social value. The genus contains several species that
are defined mainly on the basis of animal host specificity
[1]. A growing interest in development of tools for molec-
ular epidemiology and control of brucellosis has resulted
in a large amount of published genome sequence data.
The complete genome sequences of B. melitensis [2], B. suis
[3], and two B. abortus strains [4,5] are already published,
and the genome sequences of B. ovis, B. canis and the B.
abortus vaccine strain S19 are also completed but not pub-
lished yet.
The genus Brucella bears an Insertion sequence (IS) ele-
ment, originally detected in Brucella ovis as a repeated pol-
ymorphic DNA sequence in 1990 [6]. Subsequently, this
repeat was proposed to be an IS based on its genetic
organisation, which is similar to that of some elements
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described before, and named as IS711 [7] or IS6501 [8]. IS
elements are defined as small segments of DNA with a
simple genetic organisation and capable of inserting at
multiple sites into target DNA molecules. The best known
ISs are those of the Gram-negative bacteria, but these
mobile elements have been widely reported in a variety of
bacterial genera. A compilation of the available data on
insertion sequences can be found in the IS database [9].
IS711 is an 842 bp element bounded by 20 bp imperfect
inverted repeats. This IS contains two overlapping open
reading frames, which are believed to translate into a sin-
gle polypeptide by means of a -1 frameshift of the transla-
tion apparatus, a feature also present in other ISs [10,11].
IS711 appears to duplicate the dinucleotide TA of the con-
sensus target site, YTAR [7].
IS711 is exclusively present in the genome of all described
species of the genus Brucella. The sequenced genomes of
closely related α-proteobacteria do not contain an IS obvi-
ously related to IS711, suggesting that this insertion
sequence is an element native to the genus Brucella. Fur-
thermore IS711 has been shown to be associated with the
repeated elements BRU-RS1 and BRU-RS2 that could rep-
resent insertion hot spots for this IS [12,13].
Some published work already suggested that IS711 could
be an active transposon [14]. The copy number of IS711 is
different in the species of the genus. B. melitensis has 7
copies of this element; the same number as B. abortus and
B. suis. However, B. ovis contains about 35 copies [7,8],
and the recently discovered Brucella from marine mam-
mals carry more than 20 IS711 copies [15]. Furthermore,
the finding of a new IS711 copy inactivating the wboA
gene in the vaccine strain RB51[14] also indicated that
IS711 could be an active element. However, there is no
experimental evidence of IS711 transposition up to now.
Due to its proven genomic stability, IS711 has been used
as a target to identify Brucella species and biovars [12,16].
Other ISs have been described in Brucella in addition to
IS711, such as the elements named ISBm1, ISBm2 and
ISBm3  [17] and ISBm4  [18], as well as IS2020, which
forms part of the composite transposon Tn2020 [19], but
the mobility of these elements has not been observed
experimentally.
In this study we report evidence for IS711 transposition
from B. ovis and B. pinnipedialis by using pGBG1, a plas-
mid for isolating mobile DNA elements [20]. This consti-
tutes the first experimental report of activity of a
transposon in the genus Brucella.
Results and discussion
Isolation and characterisation of tetracycline resistant 
derivatives of PGBG1 in Brucella
The transposon trap plasmid pGBG1 was introduced into
Brucella by conjugation as described in the Materials and
Methods. Plasmid PGBG1 carries a tetracycline resistance
gene whose transcription is blocked by the repressor of
bacteriophage lambda. Insertions of resident transposons
into the repressor gene result in transcription of the TcR
gene of pGBG1 and can be selected on tetracycline con-
taining media. As a preliminary step for the transposition
experiments, we determined the stability of pGBG1 and
the MIC of tetracycline for the different Brucella species to
be used, since this plasmid had not been employed before
in this genus. As result of these studies we found that Bru-
cella strains must be grown in the presence of chloram-
phenicol in order to maintain pGBG1, and also
determined that the most appropriate tetracycline concen-
tration to avoid the appearance of spontaneous mutants
in plasmid free Brucella was 30 μg ml-1. To assay for trans-
position, various independent colonies (10–20) of each
Brucella strain carrying pGBG1 were grown in appropriate
media. Cultures (0.1 ml) were then plated separately on
agar plates with 30 μg ml-1 of tetracycline or with 25 μg ml-
1 of chloramphenicol (after dilution), and incubated at
37°C in 5% CO2 atmosphere until growth was observed.
The frequencies of occurrence of tetracycline resistant col-
onies relative to chloramphenicol resistant CFU's ranged
from 10-7 to 10-9, depending on the strain (Table 1). To
determine whether the appearance of tetracycline resistant
colonies was due either to transposition into pGBG1 of a
Brucella  transposon or to any other mutational event,
selected colonies from each independent experiment were
analysed by PCR using the primers G11 and G12 (Fig. 1,
Table 2), which amplified the selection cartridge of
Table 1: Frequencies of appearance of TcR mutants in Brucella containing pGBG1
Strain Frequency of TcR 
mutants*
Number of TcR 
mutants analysed
Number of mutants 
with insertions
% of insertions 
detected
Mobile element 
involved
B. ovis BOC22 (20) 8.6 × 10-8 52 30 57.7 IS711
B. abortus RB51 (10) 2.9 × 10-9 46 0 0 none
B. melitensis 16M-N (10) 3.05 × 10-7 13 0 0 none
B. pinnipedialis B2/94 (10) 5.0 × 10-8 35 4 11.4 IS711
* Average frequency of all experiments. The number of independent experiments is in parenthesesBMC Microbiology 2008, 8:17 http://www.biomedcentral.com/1471-2180/8/17
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pGBG1 plasmid as a 1.2 kb fragment. Some of the tetracy-
cline resistant isolates produced a PCR amplification frag-
ment of around 2.0 kb. The size of these DNA fragments
represented an increase of approximately 0.8 kb relative to
the size of the target region of pGBG1, which was consist-
ent with the integration of a copy of IS711 into the repres-
sor controlling the tetracycline resistance gene of pGBG1.
From the four Brucella strains in which the transposon
trap pGBG1 was used, only B. ovis BOC22 and B. pinnipe-
dialis B2/94 produced tetracycline resistant plasmids con-
taining insertions (Fig. 2). No tetracycline resistant
colonies containing insertions in the experiments that
used B. abortus or B. melitensis as hosts were obtained.
Some tetracycline resistant colonies were obtained with
these two donors. PCR analysis of the corresponding plas-
mids in these cases, (and in some colonies from B. ovis
and B. pinnipedialis as well) could not be explained by
integration events. These resistant mutants probably
resulted from point mutations (when the size of target
region was apparently unchanged) or from deletions
(when the size of target region decreased) in the pGBG1
selection cartridge (Fig. 1).
Identification of IS711 in pGBG1 TcR insertions
As a first step towards identification of the DNA inserted
into the tetracycline resistant insertional mutants, the PCR
products were digested with the restriction enzyme HaeIII.
Six different restriction patterns were observed, four in B.
ovis BOC22 (C, D, E and F) and two in B. pinnipedialis B2/
94 (A and B, Fig. 3A).
To confirm whether the insertions were due to integration
of IS711 into pGBG1, the HaeIII digested PCR products
containing insertions were transferred to a nylon mem-
brane and hybridised with an IS711  probe. Southern
hybridisation analysis showed that all insertions in
pGBG1 were due to the presence of IS711 (Fig. 4).
The different restriction patterns obtained with HaeIII
could indicate that the IS had inserted in different posi-
Table 2: Oligonucleotide primers
Primer name Sequence 5'-3' Reference
711u CACAAGACTGCGTTGCCGACAGA This study
711d CATATGATGGGACCAAACACCTAGGG This study
G11 TATCAGCTATGCGCCGACCAGAAC [20]
G12 GCCAATCCCCATGGCATCGAGTAA [20]
REPTC1 GGCGTTATAAGCATTTAATG This study
REPTC2 AAAAAGAAACCATTAACACA This study
ISOUT1 GCGGCCGGGCGTACCAACTCG This study
ISOUT2 GCTATCGTCGTATTGCGCTGC This study
Schematic drawing showing the selection cartridge of the plasmid pGBG1 after the insertion of IS711 Figure 1
Schematic drawing showing the selection cartridge of the plasmid pGBG1 after the insertion of IS711. Brucella 
strains containing these plasmids were resistant to tetracycline. The IS711 insertion is represented by a white box flanked by 
grey arrowheads. The target sequence is indicated and the duplicated bases appear as underlined capital letters. The primers 
used to amplify and determine the precise location of insertions in the selection cartridge are indicated with the primer name 
and black arrow heads.
pM pR tetA
cI
REPTC2
REPTC1
tcataaattgcttTA TAaggcgacgtgcgt
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tions of the target gene, but could also be the result of
IS711 sequence polymorphism in B. ovis and B. pinnipedi-
alis, as both species are poorly characterised. In order to
clarify this point, the PCR products obtained from
selected tetracycline resistant insertional mutants
(pGBG1::IS711) were purified and sequenced with the
ISOUT1/ISOUT2, and the REPTC1/REPTC2 pairs of prim-
ers (Fig. 1 and Table 2).
Sequence analysis of the IS711 inserted copies
Twenty one PCR products from pGBG1::IS711  tetracy-
cline resistant mutants were selected to determine the
complete sequence of the IS711 copy which integrated
into cI gene. The sequence analysis showed that all the
IS711 insertions had taken place at the same point within
the cI gene, near its 5' terminal end. In all cases the inser-
tion occurred at the sequence TTAA according to the pre-
dicted IS711  target. The central dinucleotide TA was
duplicated at both sides of the element as was expected.
IS711 insertions at this point occurred in the two possible
orientations. It was surprising to find that all the IS711
insertions occurred in the same point of the cI gene. Trans-
posons vary in the degree of target specificity from highly
specific (i.e. Tn7) to near random insertion transposons
[21]. The observance of a single insertion site among 40
independent transposition experiments indicated a strong
degree of specificity in target selection. The reported target
for IS711  integration was the very frequent YTAR
sequence. However, a preference for insertion of IS711
into the Bru-RS palindromic repeats has also been
reported, indicating the existence of some undetermined
determinants of integration specificity. Our experimental
system can only detect insertions into the 1 kb cI gene,
which contains around fifteen YTAR sites. The reason for
the observed transposition preference for a single site
remains unexplained.
Sequence analysis indicated the presence of four different
copies of IS711 disrupting the cI gene. Each copy was des-
ignated with a different nomenclature: IS711-IsoA, IS711-
IsoB, IS711-IsoC and IS711-IsoD. Nucleotide sequences
of these IS711  copies were compared with the copy
named IS711A from B. ovis (GenBank Accession number:
M94960). The copy designated as IS711-IsoB was identi-
PCR analysis of the plasmids found in tetracycline resistant mutants Figure 2
PCR analysis of the plasmids found in tetracycline resistant mutants. PCR with primers G11 and G12 was carried 
out in order to amplify the selection cartridge of pGBG1 in tetracycline resistant mutants obtained in Brucella. The black arrow 
indicates the position of the PCR fragment obtained from pGBG1/TcR mutants due to insertions encountered in B. ovis BOC22 
and B. pinnipedialis B2/94 strains (Lanes 3, 7, 8, 9, 10, 12, 13, 14 and 15). Mutants due to deletions and point mutations (Lanes 2, 
4, 5, 6, 11, 16, 17 and 18) produced PCR products of the same size or smaller than the vector pGBG1 (Lane 1). M: Molecular 
Weight Marker 1 Kb plus DNA Ladder.1. Lane 19. Negative control (PCR reaction mixture without DNA).
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Diversity of restriction profiles and nucleotide sequence of IS711 copies recovered in IS711 insertions in pGBG1 Figure 3
Diversity of restriction profiles and nucleotide sequence of IS711 copies recovered in IS711 insertions in 
pGBG1. A) PCR products from several pGBG1/TcR mutants digested with HaeIII. Lanes 1 to 6 contain insertions obtained in 
B. pinnipedialis B2/94. Lanes 7–10 insertions obtained in B. ovis BOC22 Lane 11, PCR product from pGBG1. M: Molecular size 
marker (1 Kb DNA ladder, Invitrogen). Letters under the picture indicate the different restriction patterns obtained. In B) the 
nucleotide sequences of the IS711 copies transposed into cI lambda repressor gene were compared with IS711A from B. ovis 
(GenBank Accession number: M94960). Only the variable regions and the HaeIII sites are shown. Identical nucleotides are rep-
resented by dots. Numerals in the top indicate the positions where nucleotide changes occur. Nucleotide substitutions are 
boldface and shaded. The HaeIII restriction sites are indicated within open boxes.
A 
 B 
                 5   146    160 472    502    549  579    603    648    788 822 
 IS711A      GGGCT...GGCC...T...GGCC...GGCC...GA...AGCC...GGCC...GGTC...C...A... 
 IS711-IsoA  GGGCC...GGCC...T...GGCC...GGCC...GA...AGCC...GGCC...GGTC...C...A... 
 IS711-IsoB  GGGCT...GGCC...T...GGCC...GGCC...GA...AGCC...GGCC...GGTC...C...A... 
 IS711-IsoC  GGGCT...GGCC...T...GGCC...GGCC...GA...AGCC...GGCC...GGTC...T...G... 
 IS711-IsoD  GGGCT...CGCC...C...GGCC...GGCC...AG...GGCC...GGCC...GGCC...C...G... 
 consensus   GGGCT...GGCC...C...GGCC...GGCC...GA...AGCC...GGCC...GGTC...C...G...
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cal to IS711A. Differences between other IS711  copies
were due to a few nucleotide substitutions that in some
cases led to the appearance or disappearance of some of
HaeIII restriction sites (Figure 3b). These sequence differ-
ences were responsible of the remaining diversity in
HaeIII digestions shown in Fig. 3. Some of these nucle-
otide changes were silent and the putative transposases of
the different IS711 copies were identical to that of IS711A,
with the exception of IS711-IsoD which was different to
other copies by 3 amino acids which were Gly in place of
Arg, Lys replacing Glu and Val instead of Ala.
These results demonstrate that some of the IS711 copies in
B. ovis and B. pinnipedialis were transpositionally active
even when the observed transposition frequency was very
low. We were unable to precisely determine transposition
frequencies with this assay but if we consider that the tet-
racycline resistant colonies selected for analysis were rep-
resentative of the whole population, we know that 57.7%
of the mutants obtained in B. ovis and 11.4% of those
obtained in B. pinnipedialis were due to IS711 transposi-
tion (Table 1). These percentages allowed us to estimate
the average transposition frequency around 10-8 in both
species. These frequencies are low when compared with
other transposons.
Transposition activity of IS711
Transposition of IS711 was detected only in B. ovis and B.
pinnipedialis. We were unable to detect transposition
either in B. abortus or in B. melitensis under the same exper-
imental conditions. Many attempts to detect IS711 trans-
position in E. coli from plasmids containing cloned copies
of IS711  were also unsuccessful, even when powerful
detection systems as the sacB transposon trap [22] were
used (data not shown). All these data indicated that IS711
transposition activity was very low, restricted to Brucella
maybe due to the requirement for specific host factors,
and only detectable in species with a high number of cop-
ies of IS711 per genome. The presence of some IS711 cop-
ies in these species encoding a full length transposase
without the need for a frameshift event, could explain the
observed transposition capability. However, such a copy
of IS711 has not been observed in the genomic sequence
of B. ovis released recently to GenBank and a gene dosage
Southern blot hybridisation of amplified regions from TcR mutants showing the insertion of IS711 Figure 4
Southern blot hybridisation of amplified regions from TcR mutants showing the insertion of IS711. PCR products 
obtained with primers G11 and G12 from several pGBG1/TcR insertion mutants were digested with HaeIII and hybridised with 
an IS711 probe. Lane 1: IS711 probe, lanes 2–10: insertion mutants containing IS711, lane 11: PCR product from pGBG1. 
Molecular sizes of the fragments are indicated in bp.
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effect is a more favoured hypothesis for transposition in B.
ovis and B. pinnipedialis. The requirement for many copies
of the IS could be due either to a very low level of expres-
sion of the transposase, requiring an increased dose effect
for activity, or to the presence of point mutations leading
to inactivity of some of the copies found in B. abortus and
B. melitensis. There are several reasons that could explain a
low level of IS711 transposase expression. Firstly, that the
regular initiation codon for IS711 OrfA is GTG, a less effi-
cient initiation codon than the canonic ATG. Secondly,
that a -1 frameshift could be necessary in order to have an
active IS711 transposase molecule. This event is usually
very inefficient with less than 5% of the translation prod-
ucts shifted to translate into the complete transposase.
Furthermore, in some insertion sequences OrfA possesses
an inhibitory action on the transposition process [23].
We examined the nucleotide sequence of the IS711 copies
in the genomes of the three sequenced Brucella species and
analysed them to detect the reasons for their inactivity. In
some of the copies either OrfA or OrfB were truncated or
altered by single nucleotide insertions or deletions. Fur-
thermore, we found that in many of these copies the start
codon for OrfA was TTG instead of GTG as happens in all
the copies rescued after inactivation of the cI repressor in
pGBG1. TTG has been reported to be less efficient than
GTG as a translation initiation codon [24]. These data
support that the lack of activity observed in B. abortus and
B. melitensis as well as the low transposition frequency
observed in B. ovis and B. pinnipedialis could be due to the
low expression (translation) of the IS711 transposase pro-
tein.
Position of IS711 copies in the chromosomes of the published Brucella genomes Figure 5
Position of IS711 copies in the chromosomes of the published Brucella genomes. The two blocks contain the large 
and the small chromosomes respectively. Key to the species: S, B. suis; M, B. melitensis; A9, B abortus 9_941; A8, B abortus 2308; 
O, B. ovis. Common copies numbered from 1 to 6 are marked on the top. xs, xiii, x-08 and xa are IS711 species specific copies. 
The inverted segment of B. abortus chromosome II is marked in grey.BMC Microbiology 2008, 8:17 http://www.biomedcentral.com/1471-2180/8/17
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Distribution and analysis of IS711 in the Brucella 
sequenced genomes
The reported sequence of IS711 [7], (GenBank accession
M94960) was compared with the available Brucella
genomic sequences using local BLAST searches. The
results showed the presence of 7 IS711 copies in B. suis
and B melitensis. B abortus 9_941 also presented 7 IS711
copies but one of them was severely truncated and
reduced to a 100 bp terminal remnant. B. abortus 2308
contained the same IS711 copies as the strain 9_941 and
one additional IS711  copy located at exactly the same
position as one of the pre-existing copies. It is well known
that the B. abortus vaccine strain RB51, which is a deriva-
tive of 2308, contains an extra copy of IS711 interrupting
the wboA gene [14].
The genome of B. ovis was known to contain a high copy
number of IS711 estimated by hybridisation in around 30
copies [8]. The genome sequence of this species has been
recently deposited in GenBank (Accesion Numbers
CP000708 and CP000709). Genome sequence analysis
revealed the presence of 38 complete copies of IS711 in
the  B. ovis genome, 25 and 13 in each chromosome
respectively. Upon analysis of the genomic location of the
IS711 copies we could determine that the position of six
out of the seven copies was conserved in all the Brucella
species. Four of the conserved copies were found in the
large chromosome and two in the small chromosome.
The common copies will be numbered from 1 to 6 plus a
species or strain identifier (Fig. 5). When the nucleotide
sequence of individual IS copies was analyzed it was evi-
dent that some sequence divergence existed among them.
This indicated that IS sequence had drifted along with the
other chromosomal genes in Brucella. At the same time
this sequence variation allowed us to interpret the
sequence identity between IS copies in the same organism
as an indicator of recent transposition. In B. abortus the
extra copy 711_xa was found to be identical to 711_1a. In
B. abortus 2308 there is an additional IS711 copy found
next to 711_3a. This copy was also identical to 711_1a.
These observations strongly suggest that IS711_1a could
be active and also show the strong preference of IS711 to
transpose to some sites on the genome. On the other hand
the IS711 copy found in the wboA gene of the B. abortus
vaccine strain RB51 was found to be identical to 711_a6.
This finding was rather unexpected, since 711_a6 lacks the
first five nucleotides from the left IR, which would usually
result in loss of the transposition ability. Insertion of this
copy of IS711 into the wboA gene could also be explained
by a different mobility mechanism other than transposi-
tion.
If we correlate the sequence analysis with the results pre-
sented in this study, we can conclude that the natural
transposition of IS711 occurs at very low frequency, prob-
ably due to a poor expression of IS711 transposase. This
limitation can be overcome in B. ovis by the high copy
number of IS711.
Conclusion
In conclusion, our results demonstrate experimentally for
the first time that IS711 is an active insertion sequence of
the Brucellae. On the other hand, the low transpositional
activity of the sequence allows the use of this element as a
tool for molecular identification, at least for the species
containing a low number of copies of this insertion
sequence.
Methods
Bacterial strains plasmids and growth conditions
The bacterial strains and plasmids used in this study are
listed in Table 3. Escherichia coli cells were cultivated over-
night at 37°C in Luria-Bertani (LB) medium (Pronadisa).
Brucella strains were grown at 37°C for 48–96 hours in a
Table 3: Bacterial strains and plasmids used in this study
Strain/Plasmid Relevant characteristics Reference
E. coli strains
S17.1 TpR SmR, recA, thi, pro, hsdR-M+ RP4: 2-Tc:Mu: Km Tn7 λ pir [30]
Brucella strains
B. abortus RB51 RifR, rough mutant of 2308 [31]
B. melitensis 16M-N Spontaneous NalR mutant of ATCC 23456 This study
B. ovis BOC 22 Rough field strain, CO2 dependent This study
B. pinnipedialis B2/94 Brucella marine strain isolated from common seal, CO2 dependent [32]
Plasmids
pGBG1 CmR, transposon trap derivative of pBBR-MCS1 [20]
CmR: Chloramphenicol resistant, NalR: Nalidixic acid resistant, RifR: Rifampicin resistant, TpR: Trimethoprim resistant, SmR: Streptomycin resistant,BMC Microbiology 2008, 8:17 http://www.biomedcentral.com/1471-2180/8/17
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5% CO2 atmosphere in Brucella broth (BB) (Pronadisa),
Blood agar (Difco) or Brucella agar (BA) medium (Pron-
adisa). Plates were supplemented with 10% foetal bovine
serum to grow B. ovis and B. pinnipedialis.
pGBG1 (courtesy of M. Blot), is a derivative from the
broad host-range, mobilizable plasmid pBBR1-MCS [25]
containing a transposition selection module with a tetra-
cycline resistance gene (tetA) whose expression is blocked
by λ repressor cI. This plasmid allows positive selection
for tetracycline resistance of transposon insertions inacti-
vating the repressor [20].
General DNA manipulations, PCR and Southern blot 
hybridisations
DNA preparations, purifications, restriction endonuclease
digestions and agarose gel electrophoresis were carried
out according to described standard protocols [26].
Oligonucleotide primers used in this study were pur-
chased from MWG Biotech and are listed in Table 2. PCR
reactions were usually performed in 25 μl reaction vol-
umes containing 0.2 μM of each primer, 2.5 μl of 10× PCR
reaction buffer, 1.5 mM of MgCl2, 0.2 mM of dNTPs
(Applied Biosystems), 25 ng of template DNA and 1 unit
of BioTaq DNA polymerase (Bioline). Amplification was
performed in a thermal cycler (GeneAmp PCR System
2400, Perkin Elmer) as follows: denaturation step at 94°C
for 3 min and 25 cycles of 94°C for 30 s, 50°C for 30 s and
72°C for 1 min. After the last cycle the reaction mixture
was reincubated at 72°C for 5 min.
Preparation of the IS711 probe was performed by PCR
amplification with two primers, 711u and 711d, using
genomic DNA from B. melitensis 16 M as template. The
PCR reaction was carried out as described and the ampli-
fied DNA fragment to be used as a probe was recovered
from an agarose gel by using the QIAquick Gel Extraction
Kit (QIAGEN). The probe was labelled with digoxigenin
using a DIG-High Prime DNA Labelling and Detection Kit
(Roche Diagnostics GmbH) as described by the supplier.
Southern blot hybridisation with the DIG-labelled probe
was performed as described before [27].
Conjugation experiments
Introduction of plasmid pGBG1 into Brucella  was per-
formed by conjugation from E. coli S17.1. The experi-
ments were carried out by filter mating as follows. Equal
volumes (500 μl) of mid-log-phase cultures of E. coli S.17
(pGBG1) as donor and B. abortus RB51, B. melitensis 16M-
N, B. ovis BOC22 or B. pinnipedialis B2/94 as recipients
were mixed and then washed with sterile PBS by centrifu-
gation. The mixtures were spread on 0.22 μm filters (24
mm diameter, GSWP, Millipore), placed on a Brucella agar
plate and incubated at 37°C for 12 h in 5%
CO2atmosphere. After this period of incubation the filters
with the conjugation mixtures were washed in 3 ml of BB
medium. Different serial dilutions (10-1-10-3) of the con-
jugation mixtures were plated onto the appropriated
media until growth was observed. The transconjugants of
B. melitensis 16M-N and B. abortus RB51 were selected on
Brucella agar medium with chloramphenicol (25 μg ml-1)
and either nalidixic acid (20 μg ml-1) or rifampicin (50 μg
ml-1) respectively. Transconjugants of B. ovis BOC22 and
B. pinnipedialis B2/94 strains were selected on BA medium
supplemented with 10% of foetal bovine serum contain-
ing chloramphenicol (25 μg ml-1) and a mixture of antibi-
otics (vancomycin, 3 μg ml-1; colistin, 7.5 μg ml-1; nystatin
12.5 units ml-1 and nitrofurantoin 10 μg ml-1) to coun-
terselect against the donors. The presence of pGBG1 in the
transconjugants was confirmed by extraction of plasmid
DNA and analysis on agarose gels.
DNA sequencing and data analysis
PCR products were purified for sequencing by using the
QIAquick Gel Extraction Kit (QIAGEN). All PCR products
were sequenced by our Sequencing Service using a com-
mercial cycle sequencing kit (Perkin Elmer, Dye Termina-
tor Cycle Sequencing Ready Fraction Kit) according to the
manufacturer's conditions. Both, the nucleotide and pro-
tein sequence analysis of the different IS711 copies iso-
lated from each Brucella strains were performed by using
the Vector NTI version 5.5 computer program (Informax
Inc.). Sequences were compared with the IS711  copies
reported in GenBank with the BLAST sequence compari-
son tool [28].
Preliminary sequence data of the B. ovis genome was
obtained from The Institute for Genomic Research [29]
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